Escitalopram for first-time depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and of Han Chinese ethnicity.
- You have been diagnosed with major depression for the first time, for no more than 3 months.
- You have never taken antidepressants or other psychiatric medications.
- You score at least 17 on a standard depression scale (HAMD-17).
- You do not have other mental health conditions like bipolar disorder or psychosis.
- You are not pregnant, breastfeeding, or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a non-drug brain stimulation technique (called tACS) that uses gentle electrical currents to help regulate mood in teenagers with first-episode depression who have not yet taken antidepressants. If effective, it could offer a drug-free option for managing depression.
This trial tests whether transplanting healthy gut bacteria (fecal microbiota) can help people with depression that does not respond well to the antidepressant escitalopram. You will first take escitalopram for 2 weeks, and if it doesn't help enough, you may receive either the real transplant or a placebo capsule.
This study looks at how the body processes escitalopram (an antidepressant) differently in women before and after menopause. It aims to help doctors understand if dosing should be adjusted based on menopausal status.
This study tests whether adding acupuncture to a common antidepressant (escitalopram) helps improve depression symptoms more than the medication alone. It aims to see if this combination can be a safe and effective treatment for adults with major depression.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This trial tests whether adding a special fish oil supplement (CreNeuroS) to the antidepressant escitalopram helps improve depression symptoms more than escitalopram alone. If you have moderate to severe depression and are starting or recently started escitalopram, this study may help you find a more effective treatment.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.